IP Library › Granted Patent US 12,649,938
Granted Patent B2
US 12,649,938 · App. 17/754,988 · Granted Jun 9, 2026

L-methionine producing microorganism to which protein encoded by foreign

Inventors: Sol Choi (Seoul, KR); Jin Nam Lee (Seoul, KR); Hee Ju Kim (Seoul, KR); Jin Ah Rho (Seoul, KR); Han Hyoung Lee (Seoul, KR)
Assignee: CJ CHEILJEDANG CORPORATION
C12P13/12C12N9/1085C12N15/77C12Y205/01C12N2800/101
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,649,938
App. No.
17/754,988
Granted
Jun 9, 2026
Kind
B2
Abstract

An L-methionine-producing microorganism into which a met Z gene is introduced and a method of producing L-methionine using the same.

Claims (22)

1 . A method of producing L-methionine, the method comprising culturing an L-methionine producing microorganism of the genus Corynebacterium , into which a protein encoded by a foreign met Z gene is introduced, in a medium containing thiosulfate, thereby producing L-methionine, wherein the protein has O-acylhomoserine transsulfurase activity.

2 . The method of producing L-methionine of claim 1 , wherein the protein is derived from Chromobacterium violaceum, Hyphomonas neptunium , or Rhodobacter sphaeroides.

3 . The method of producing L-methionine of claim 1 , wherein the protein has at least 90% sequence identity to SEQ ID NOS: 60, 61, or 62.

4 . The method of producing L-methionine of claim 1 , wherein the microorganism includes one or more genetic modifications selected from the group consisting of attenuation or inactivation of activity of cystathionine gamma synthase; attenuation or inactivation of activity of O-acetylhomoserine sulfhydrylase; attenuation or inactivation of activity of methionine-cysteine biosynthesis repressor protein; enhancement of activity of methionine synthase; and enhancement of activity of sulfite reductase,

wherein the enhancement of activity of the polypeptide or protein is achieved by:

1) a method of increasing the intracellular copy number of a gene or polynucleotide encoding the polypeptide or protein;

2) a method of replacing a gene expression regulatory region on the chromosome encoding the polypeptide or protein with a sequence having a strong activity;

3) a method of modifying a nucleotide sequence of a start codon or 5′-UTR region of the polypeptide or protein;

4) a method of modifying a polynucleotide sequence on the chromosome to increase the activity of the polypeptide or protein;

5) a method of introducing a foreign polynucleotide exhibiting the activity of the polypeptide or protein, or introducing a variant polynucleotide by codon-optimization of the polynucleotide; or

6) a combination of two or more selected from 1) to 5) above,

wherein the inactivation or attenuation of the activity of the protein is achieved by:

1) a method of deleting all or a part of the gene encoding the protein;

2) a method of modifying the expression regulatory region (or expression regulatory sequence) such that the expression of the gene encoding the protein is decreased;

3) a method of modifying the gene sequence encoding the protein such that the protein activity is removed or weakened;

4) a method of introducing an antisense oligonucleotide that binds complementarily to a transcript of the gene encoding the protein;

5) a method of adding a complementary sequence to the Shine-Dalgarno sequence upstream of the Shine-Dalgarno sequence of the gene encoding the protein to form a secondary structure, thereby inhibiting the ribosomal binding;

6) a reverse transcription engineering (RTE) method of adding a promoter at the 3′ terminus of an open reading frame (ORF) of the polynucleotide sequence of the gene encoding the protein so as to be reversely transcribed; or

7) a combination of two or more selected from 1) to 6) above.

5 . The method of producing L-methionine of claim 1 , wherein the microorganism is Corynebacterium glutamicum.

6 . The method of producing L-methionine of claim 1 , comprising recovering L-methionine from the microorganism or medium.

7 . The method of producing L-methionine of claim 1 , wherein homolanthionine production is reduced.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2022
From: CHOI, SOL; LEE, JIN NAM; KIM, HEE JU; RHO, JIN AH; LEE, HAN HYOUNG
To: CJ CHEILJEDANG CORPORATION
Reel/Frame 059916/0458 →
Priority Claims (1)
KR 10-2019-0134797 · Oct 28, 2019 · national
Continuity (1)
Related Publication 20230212623A1 · Jul 6, 2023
References Cited (43)
US 7662943B2 · Park et al. · 2010 [cited by applicant]
US 10273491B2 · Lee et al. · 2019 [cited by applicant]
US 10584338B2 · Lee et al. · 2020 [cited by applicant]
US 12203117B2 · Choi · 2025 [cited by examiner]
US 12331339B2 · Choi · 2025 [cited by examiner]
US 20030162267A1 · Pompejus et al. · 2003 [cited by applicant]
US 20040043953A1 · Pompejus et al. · 2004 [cited by applicant]
US 20060084152A1 · Pompejus · 2006 [cited by examiner]
US 20090298137A1 · Zelder et al. · 2009 [cited by applicant]
US 20100009416A1 · Zelder et al. · 2010 [cited by applicant]
US 20100184164A1 · Kim et al. · 2010 [cited by applicant]
US 20130273614A1 · Kim et al. · 2013 [cited by applicant]
US 20180223319A1 · Soucaille · 2018 [cited by examiner]
US 20180355389A1 · Lee et al. · 2018 [cited by applicant]
JP 2009501550 · 2009 [cited by applicant]
JP 2010523145 · 2010 [cited by applicant]
KR 100905381B1 · 2009 [cited by applicant]
KR 20120108844A · 2012 [cited by applicant]
KR 101250651B1 · 2013 [cited by applicant]
KR 101783170B1 · 2017 [cited by applicant]
RU 2447146 · 2012 [cited by applicant]
WO WO02051231A1 · 2002 [cited by applicant]
Chica et al. Curr Opin Biotechnol. Aug. 2005;16(4):378-84. (Year: 2005). [cited by examiner]
Singh et al. Curr Protein Pept Sci. 2017, 18, 1-11 (Year: 2017). [cited by examiner]
Kizer et al. Appl Environ Microbiol. May 2008;74(10):3229-41. (Year: 2008). [cited by examiner]
Prather et al. Curr Opin Biotechnol. Oct. 2008;19(5):468-74. (Year: 2008). [cited by examiner]
Accession Q7NUH3. Dec. 15, 2003 (Year: 2003). [cited by examiner]
Accession A0A059FLS2. Jul. 9, 2014 (Year: 2014). [cited by examiner]
Accession Q3J5D4 Nov. 8, 2005 (Year: 2005). [cited by examiner]
Extended European Search Report in European Patent Application No. 20883239.4, mailed Apr. 18, 2023. [cited by applicant]
Office Action in Japanese Patent Application No. 2022-523724, dated Mar. 14, 2023. [cited by applicant]
Kromer JO et al., J Bacteriol 188(2):609-618, 2006. [cited by applicant]
Yeom HJ et al., J Microbiol Biotechnol 14(2):373-378, 2004. [cited by applicant]
Hwang BJ et al., J Bacteriol 184(5):1277-1286, 2002. [cited by applicant]
Pearson et al., Proc. Natl. Acad. Sci. USA 85:2444, 1988. [cited by applicant]
Sitnicka et al. “Functional Analysis of Genes”. Advances in Cell Biology. 2010, vol. 2. 1-16; Sambrook et al. Molecular Cloning 2012. [cited by applicant]
Nakashima N et al., “Bacterial cellular engineering by genome editing and gene silencing”. Int J Mol Sci. 2014;15(2):2773-2793. [cited by applicant]
Sambrook et al. Molecular Cloning 2012. [cited by applicant]
Rey et al., J. Biotechnol. 103:51-65, 2003. [cited by applicant]
Van der Rest et al., Appl Microbiol Biotechnol 52:541-545, 1999. [cited by applicant]
Office Action received in Brazilian Patent Application No. BR112022007907-9, dated Sep. 11, 2024. [cited by applicant]
Taté, Rosarita, et al. “The Rhizobium etli [cited by applicant]
Office Action received in Russian Application No. 2022111721, dated Dec. 21, 2022. [cited by applicant]